Title : A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor.

Pub. Date : 1995 Nov 3

PMID : 7592869






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 FK506, an immunosuppressant that prolongs allograft survival, is a co-drug with its intracellular receptor, FKBP12. Tacrolimus FKBP prolyl isomerase 1A pseudogene 1 Homo sapiens
2 The FKBP12.FK506 complex inhibits calcineurin, a critical signaling molecule during T-cell activation. Tacrolimus FKBP prolyl isomerase 1A pseudogene 1 Homo sapiens
3 FKBP12 was, until recently, the sole FKBP known to mediate calcineurin inhibition at clinically relevant FK506 concentrations. Tacrolimus FKBP prolyl isomerase 1A pseudogene 1 Homo sapiens
4 In transfected Jurkat cells, FKBP12.6 is equivalent to FKBP12 at mediating the inhibitory effects of FK506. Tacrolimus FKBP prolyl isomerase 1A pseudogene 1 Homo sapiens